Case Study: Accelerating Performance in a Phase III CVOT Rescue Program for a Mid-Size Biotech
Rescuing a Stalled Cardiovascular Outcomes Trial Through Targeted Operational Intervention
When a Phase III cardiovascular outcomes trial (CVOT) faced significant enrollment delays and timeline risk, Julius Clinical was engaged to support and accelerate study delivery alongside an incumbent CRO. This case study demonstrates how a focused rescue strategy, combining deep cardiometabolic expertise, experienced site engagement, rapid global activation, and integrated operational oversight, helped reverse recruitment challenges and improve trial performance across a complex multinational program.
Download the full case study to learn how our specialized CVRM teams support rescue studies and drive successful delivery of large-scale cardiovascular outcomes trials.
Related resources
Case Study: Supporting Global Delivery of a Phase III Cardiovascular Outcomes Trial for a Global Top-10 Pharmaceutical Company
Executing a Complex Phase III Diabetes Cardiovascular Outcomes Trial in a High-Risk Population Cardiovascular outcomes trials (CVOTs) in type 2 diabetes present a unique combination of clinical, operational, and regulatory complexity, particularl...
